• Patient Safety Notice: Astellas recall of certain lots of immunosuppressant capsules
  Friday, December 27, 2024
  No other lots or forms of the medication are affected.
  

• A message from the OPTN Board President regarding organ donation process questions
  Thursday, December 26, 2024
  Memo addresses comments spurred by recent news coverage.
  

• OPTN response to HRSA data directive available for viewing
  Wednesday, December 18, 2024
  Comment offers detailed feedback on proposed new data collection.
  

• OPTN Board approves updates to bylaws, new procedures for OPTN computer system access
  Monday, December 9, 2024
  Update support recent establishment of independent OPTN Board.
  

• Nominations sought for the OPTN’s Transitional Nominating Committee
  Friday, December 6, 2024
  Submit response by Dec. 13, 2024.
  

• Rexanah Wyse Morrissette named interim OPTN executive director
  Thursday, December 5, 2024
  Her selection followed a national search.
  

• Two-year monitoring report showing effect of eGFR policy change available
  Monday, December 2, 2024
  Committees will continue to study ways to improve access to kidney transplantation.
  

• OPTN Board approves update to transplant program outcome monitoring criteria; expected to increase organ usage, reduce waitlist deaths
  Monday, December 2, 2024
  Action adjusts threshold for review of transplant program outcomes.
  

• Comments sought on OPTN data collection relating to data directive
  Monday, November 25, 2024
  Sixty-day public comment period ends January 3, 2025.
  

• Comments sought on proposed new and updated OPTN data collection initiatives
  Monday, November 25, 2024
  Package addresses data collection updates relating to six OPTN projects.
  

Click on a page number to view more news in chronological order.